Teach me Immune thrombocytopenic purpura in simple way for pathology University examin very simple language so I can score more

Reading File

Finding Sources

Reading File

I now have excellent material from Robbins. Let me compile a clear, exam-focused answer.

Immune Thrombocytopenic Purpura (ITP) - Simple Exam Guide

Based on Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease

1. What Is ITP? (Definition - 2 marks)

ITP is a disease where your own immune system makes antibodies that destroy your platelets (the tiny cells that stop bleeding). Because platelets fall low, the patient bleeds easily.

Simple memory trick: Immune system Trashing Platelets

2. Types of ITP (Very Exam-Friendly)

Feature	Acute ITP	Chronic ITP
Who gets it	Children	Women aged 20-40
Trigger	After a viral infection	Idiopathic (no clear cause)
Course	Self-limited (gets better on its own)	Persistent, needs treatment
Prognosis	Good	Needs management

3. Causes / Secondary ITP (1-2 marks)

Chronic ITP can be primary (idiopathic) or secondary due to:

Systemic Lupus Erythematosus (SLE)
HIV infection
B-cell cancers (e.g., Chronic Lymphocytic Leukemia)
Drugs

4. Pathogenesis - HOW Does It Happen? (Most Important for Exams - 4-5 marks)

This is the heart of ITP. Learn this step by step:

Step 1 - Antibody formation The body makes IgG autoantibodies against platelet membrane proteins - mainly glycoprotein IIb/IIIa or Ib/IX complexes. These are found in ~80% of patients.

Step 2 - Platelet destruction The antibodies coat the platelets (opsonization). Phagocytes in the spleen recognize the IgG Fc portion and destroy the coated platelets.

Step 3 - Spleen is the main villain

The spleen is the main site of platelet destruction
The spleen also has plasma cells that produce more autoantibodies
This is why splenectomy (removing the spleen) helps!

Step 4 - Megakaryocytes also attacked (in some cases) Antibodies can also damage megakaryocytes in bone marrow, further reducing platelet production.

Autoantibody (IgG) → Coats platelet → Spleen phagocytes destroy it
                                    ↓
                              Low platelet count → Bleeding

5. Morphology (What You See Under Microscope / Gross - 4 marks)

Spleen:

Normal size (no splenomegaly - this is a key exam point!)
Congestion of sinusoids
Enlarged splenic follicles with prominent germinal centers
Scattered megakaryocytes in sinuses

Bone Marrow:

Increased megakaryocytes (the body is trying to make more platelets to compensate)
Some megakaryocytes are immature - large, non-lobulated, single nuclei
This is a reactive change, not specific to ITP

Key exam pearl: Increased megakaryocytes in bone marrow + low platelets in blood = peripheral destruction (not a production problem)

6. Clinical Features (Signs & Symptoms - 2-3 marks)

Onset is insidious (gradual). Look for:

Petechiae - tiny red/purple pinpoint spots on skin
Easy bruising
Epistaxis (nosebleeds)
Gum bleeding
Hemorrhage after minor trauma
Serious but rare: Intracerebral or subarachnoid hemorrhage

No fever, no splenomegaly (unlike other hematological conditions - exam trick!)

7. Lab Findings (2 marks)

Test	Result
Platelet count	LOW
Bleeding time	Prolonged
PT / PTT	Normal (clotting factors are fine)
Bone marrow	Increased megakaryocytes
Antiplatelet antibodies (IgG)	Present in ~80%

Reliable lab tests for antiplatelet antibodies are NOT routinely available in clinical practice - diagnosis is by exclusion.

8. Diagnosis (1-2 marks)

Diagnosis is clinical - based on:

Thrombocytopenia on blood count
Increased megakaryocytes on bone marrow exam
Exclusion of secondary causes (SLE, HIV, drugs, malignancy)
Clinical features of bleeding

9. Treatment (2 marks)

Immunosuppressive agents - steroids (1st line), IVIG
Splenectomy - removes the main site of platelet destruction AND autoantibody production; achieves complete remission in >2/3 of patients
Thrombopoietin receptor agonists (e.g., romiplostim) - stimulate platelet production

10. Quick Exam Summary Table

Point	Key Fact
Antibody target	Glycoprotein IIb/IIIa or Ib/IX
Antibody class	IgG
Main destruction site	Spleen
Spleen size	Normal
Bone marrow finding	Increased megakaryocytes
PT/PTT	Normal
Best treatment	Steroids + Splenectomy
Splenectomy success	>2/3 patients achieve remission
Acute ITP affects	Children (post-viral, self-limited)
Chronic ITP affects	Women 20-40 years

11. Mnemonics to Remember

ITP = "I Trash Platelets"

IgG antibodies
Target: GP IIb/IIIa
Phagocytosis in spleen

SPLEEN is Key:

Site of platelet destruction
Plasma cells make antibodies there
Low platelets result
Excision (splenectomy) = treatment
Enhanced megakaryocytes in marrow
Normal spleen size (no splenomegaly!)

These notes cover everything a pathology examiner typically asks. Focus especially on the pathogenesis (antibody mechanism), morphology, and the spleen's role - those are the highest-yield topics for marks. - Robbins Basic Pathology, p. 429; Robbins Cotran Pathologic Basis of Disease, p. 620

This is a shared conversation. Sign in to Orris to start your own chat.